维普中文期刊产品整合服务
8篇 您的检索式:作者名="Fogelman DR"
    题名 作者 年代 出处 被引量
1The gemcitabine, docetaxel, and capecitabine (GTX) regimen for metastatic pancreatic cancer: a retrospective analysis 显示文摘Fine RL Fogelman DR Schreibman SM 2008Cancer Chemother Pharmacol2008,61,1:1
2Randomized phase Ⅱ study of gemcitabine (G) plus anti-IGF-1R antibody MK-0646, G plus erlotinib (E) plus MK-0646 and G plus E for advanced pancreatic cancer显示文摘JAVLE MM VARADHACHARY GR FOGELMAN DR 2011J Clin Oncol2011,,:1
3Neoadjuvant GTX and radiation for unresectable pancreatic cancer: a pro- spective phase Ⅱ trial显示文摘Fogelman DR Sehreibman S ShermanW 2007Proc GI Am Soc Clin Oncol2007,,143:1
4Serum CA19-9 level as a surrogate marker for prognosis in locally advanced pancreatic cancer (LAPC) 显示文摘Fogelman DR Pathak P Qiao W 2008J Clin Oncol2008,26,15:1
5A prospective, multi-institutional phase Ⅱ study of GW786034 (pa- zopanib) and depot octreotide (sandostatin LAR) in ad- vanced low-grade neuroendocrine carcinoma (LGNEC)显示文摘Phan AT Yao JC Fogelman DR 2010J Clin Oncol2010,28,15:1
6Joint prognostic effect of obesity and chronic systemic inflammation in patients with metastatic coloreetal cancer显示文摘Shah MS Fogelman DR Raghav KP 2015Cancer2015,121,17:1
7Serum CA19-9level as a surrogate marker for prognosis in locally advanced pancreatic cancer(LAPC)显示文摘Fogelman DR Pathak P Qiao W 2008J Clin Oncol2008,26,15:1
8The gemcitabine, docetaxel, and capecitabine (GTX) regimen for metastatic pancre- atic cancer: a retrospective analysis显示文摘Fine RL Fogelman DR Schreibman SM 2008Cancer Chemother Phar- maco12008,61,1:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费